Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease

Autoimmunity

Volumn 43, Issue 4, 2010, Pages 317-324

  Franco, Alessandra ^a   Shimizu, Chisato ^a   Tremoulet, Adriana H ^a   Burns, Jane C ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Human T cell clones; Immune regulation; Kawasaki disease; T cell memory; Tregs

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; IMMUNOGLOBULIN; INTERLEUKIN 15;

ADAPTIVE IMMUNITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFANT; INFLAMMATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TH1 CELL; THERAPY RESISTANCE;

ACUTE DISEASE; ADAPTIVE IMMUNITY; CLONE CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 77952501592     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916930903405891     Document Type: Article

References (33)

1. Burns JC, Glodé MP. Kawasaki syndrome. Lancet 2004;364:533-544.
2. Burns JC. The riddle of Kawasaki disease. N Engl J Med 2007;356:659-661.
3. Brugner D, Davila S, Breunis WB, Ng SB, Bonnard C, Ling L, Wright VJ, Thalamuthu A, Odam M, Shimizu C, Burns JC, Levin M, Kuijpers TW, Hibberd ML. A genomic wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009;5: e1000319.
4. Burns JC, Shimizu C, Shike H, Newburger JW, Sundel RP, Baker AL, Matsubara T, Ishikawa Y, Brophy VA, Cheng S, Grow MA, Steiner LL, Kono N, Cantor RM. Family-based association analysis implicates IL-4 in susceptibility of Kawasaki disease. Genes Immun 2005;6:438-444.
5. Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005;192:344-349.
6. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, NakamuraY, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Nakamura Y, Hata A. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008;40:35-42.
7. Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001;184:940-943.
8. Franco A, Albani S. Translating the concept of suppressor/regulatory T cells to clinical applications. Inter Rev Immunol 2006;25:27-47.
9. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and to alloantigens in humans. Nat Rev 2007;7:585-598.
10. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001;2:301-306.
11. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigens. Nat Immunol 2002;3:756-763.
12. Walker LSK, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2008;198:249-258.
13. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen WJ. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008;9:632-640.
14. Chen WJ, Jin W, Hardegen N, Lei K, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-ß induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
15. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig M, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1-9.
16. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2003;3:756-763.
17. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subset of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-712.
18. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol 2004;22:745-763.
19. Sallusto F, Baggiolini M. Chemokines and leukocyte traffic. Nat Immunol 2008;9:949-952.
20. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA. Diagnosis, treatment and long term management of Kawaski disease: A statement for helath professionals from the Committee for Rheumatic Fever, Endocarditis and Kawaski Disease, Council on Cardiovascular Diseases in the Young, American Heart Association. Circulation 2004;110:2747-2771.
21. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007;8:549-551.
22. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942-949.
23. Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 2005;16:82-89.
24. Apostolou I, von Boemer H. In vivo instruction od suppressor committment in naive T cells. J Exp Med 2004;199:1401-1408.
25. Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, Bastian J, Beiser AS, Meyerson HM, Newburger JW. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 1991;118:680-686.
26. Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease-cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol 2008;6:394-401.
27. Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, Crawford SE, Russo PA, Hammadeh R, Takahashi K, Orenstein JM. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE 2008;2: e1582.
28. Faruno K, Yuge T, Kasuhara K, Takada H, Nishio H, Khajoee V, Ohno T, Hara T. CD25+CD4+ regulatory T cells in patients with Kawaski disease. J Pediat 2004;145:385.
29. Trinchieri G. Interleukin-10 production by effector cells: Th1 cells show self control. J Exper Med 2007;204:239-243.
30. O'Garra A, Vieira P. Th1 cells control themselves by producing IL-10. Nat Rev 2007;7:425-428.
31. Anderson CF, Oukka M, Kuchroo VJ, Sacks D. CD4+ CD25-Foxp3-Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 2007;204:285-297.
32. Nylen S, Radheshyam M, Eidsmo L, Das Manandhar K, Sundar S, Sacks D. Splenic accumulation of Il-10 mRNA in T cells disinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 2007;204:805-817.
33. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, Wilson M, Wynn TA, Kamanaka M, Flavell FA, Sher A. Conventional T-bet+ Foxp3-Th1 cells are the major source of host protective regulatory IL10-during intracellular protozoan infection. J Exp Med 2007;204:273-283.